Literature DB >> 10356258

Metabolic engineering from a cybernetic perspective. 1. Theoretical preliminaries

.   

Abstract

The theoretical basis of a cybernetic metabolic network design and analysis framework, which has been subsequently successfully applied to predict system response to genetic alteration, is presented. This conceptual methodology consists of three main branches, namely, a model realization framework, a representation of genetic alteration, and lastly, a metabolic design component. These concepts are introduced as a series of postulates that describe the basic tenets of the approach. Each branch is discussed in turn, starting with the cybernetic representation of arbitrarily complex metabolic networks. A set of postulates is put forth that affords the modular construction of cybernetic models of metabolic networks using as a base a library of elementary pathways. This is followed by a discussion of the representation of genetic alterations within the cybernetic framework. It is postulated that the objective of the base network and the altered system are identical (at least on the time scale required for the organism to "learn" new objectives). This implies, with respect to resource allocation, that the base network and its genetically altered counterpart may still be treated as optimal systems; however, the set of competing physiological choices open to the altered network expands or contracts depending upon the nature of the genetic perturbation. Lastly, to add a predictive design aspect to the methodology, we present a set of postulates that outline the application of metabolic control analysis to cybernetic model systems. We postulate that sensitivity coefficients computed from a cybernetic model, although still local in scope, have the added benefit of a systematic representation of regulatory function as described by the cybernetic variables. Thus, information gained from sensitivity measurements stemming from a cybernetic model include the explicit input of metabolic regulation, a component that is lacking in a purely kinetic representation of metabolic function. The sensitivity results can then be employed to develop qualitative strategies for the rational alteration of metabolic function, which can be evaluated by simulation of an appropriately modified cybernetic model of the base network.

Year:  1999        PMID: 10356258     DOI: 10.1021/bp990017p

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  7 in total

Review 1.  In Silico Constraint-Based Strain Optimization Methods: the Quest for Optimal Cell Factories.

Authors:  Paulo Maia; Miguel Rocha; Isabel Rocha
Journal:  Microbiol Mol Biol Rev       Date:  2015-11-25       Impact factor: 11.056

2.  Dynamic flux balance analysis of diauxic growth in Escherichia coli.

Authors:  Radhakrishnan Mahadevan; Jeremy S Edwards; Francis J Doyle
Journal:  Biophys J       Date:  2002-09       Impact factor: 4.033

3.  Utilizing elementary mode analysis, pathway thermodynamics, and a genetic algorithm for metabolic flux determination and optimal metabolic network design.

Authors:  Brett A Boghigian; Hai Shi; Kyongbum Lee; Blaine A Pfeifer
Journal:  BMC Syst Biol       Date:  2010-04-23

4.  A method for estimation of elasticities in metabolic networks using steady state and dynamic metabolomics data and linlog kinetics.

Authors:  I Emrah Nikerel; Wouter A van Winden; Walter M van Gulik; Joseph J Heijnen
Journal:  BMC Bioinformatics       Date:  2006-12-21       Impact factor: 3.169

5.  Discovery of metabolite biomarkers: flux analysis and reaction-reaction network approach.

Authors:  Limin Li; Hao Jiang; Yushan Qiu; Wai-Ki Ching; Vassilios S Vassiliadis
Journal:  BMC Syst Biol       Date:  2013-12-17

Review 6.  Optimization in computational systems biology.

Authors:  Julio R Banga
Journal:  BMC Syst Biol       Date:  2008-05-28

7.  k-OptForce: integrating kinetics with flux balance analysis for strain design.

Authors:  Anupam Chowdhury; Ali R Zomorrodi; Costas D Maranas
Journal:  PLoS Comput Biol       Date:  2014-02-20       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.